Possibilities ARB II (sartans) in hypertensive patients

Abstract

The article presents an overview of the literature on the choice of pharmacotherapy of arterial hypertension (AH). Among antihypertensive drugs occupy an important place ARBs II (BRA), a heterogeneous group of drugs whose representatives have significant intercompany differences. This article focuses on the properties and effects of olmesartan, that distinguish it from other ARBs. Along with a strong long-term antihypertensive effect of olmesartan has organoprotective (regression of LVH, nephroprotection etc.). Olmesartan clinical experience indicates a high efficiency and a good range of security among different categories of patients with hypertension.

Keywords

• cardiovascular disease
• hypertension
• pharmacotherapy of hypertension
• antihypertensive therapy
• the renin-angiotensin-aldosterone system
• raas
• angiotensin receptor ii
• arbs
• olmesartan
• clinical studies
• review